Anti-Recombinant-SARS-CoV-2 Spike RBD antibody [60E10] (STJA0002951)
SPECIFICATIONS
ClonalityMonoclonal
HostCHO cells
ConjugationUnconjugated
IsotypeIgG1 lambda
ImmunogenSARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies)
General Information
| Short Description | Cho Cells monoclonal anti-Recombinant-SARS-CoV-2 Spike RBD for use in ELISA in SARS-CoV-2 samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | ELISA |
| Host | CHO cells |
| Reactivity | SARS-CoV-2 |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 60E10 |
| Isotype | IgG1 lambda |
| Conjugation | Unconjugated |
| Purification | Protein A affinity chromatography following gel filtration |
| Dilution Range | Indirect ELISA 0.02 – 0.04 ng/ml |
| Formulation | PBS pH 7.4 |
| Storage Instruction | The product is stable at 4 °C for several days. Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles. |
| Dissociation Constant | <1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein) 2.22 x 10-9 M (measured against SARS-CoV-2 Spike S1 protein) |
Target Information
| Immunogen | SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies) |
| Specificity | SARS-CoV-2 Spike RBD Neutralizing properties: blocks S1 and ACE2 binding in Octet system; IC50 125 ng/ml measured in live virus neutralization assay |